Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Thoracic 1Gynecologic 1

Conditions

Ovarian Neoplasms 1

Interventions

Surveys and Questionnaires 58Blood Specimen Collection 31Surgical Procedures, Operative 13Interviews as Topic 13Immunohistochemistry 13Data Collection 13niraparib 12Hyperthermic Intraperitoneal Chemotherapy 11Observation 10Drug Therapy 10Cytoreduction Surgical Procedures 10Magnetic Resonance Spectroscopy 9Radiotherapy 8Polymerase Chain Reaction 8Papanicolaou Test 8Colposcopy 8Cisplatin 8Biopsy 8Amplified Fragment Length Polymorphism Analysis 8olaparib 7Carboplatin 7Ultrasonography 6Sentinel Lymph Node Biopsy 6Psychiatric Rehabilitation 6Paclitaxel 6Microarray Analysis 6Laparoscopy 6Hysterectomy 6DNA Methylation 6liposomal doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Combined Modality Therapy × Gynecologic × Clear all
NCT05206890 2022-01-26

A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer

Tongji Hospital

Recruiting
490 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡